Literature DB >> 32199542

Hospitalization outcomes of people who use drugs: One size does not fit all.

Elisabeth Merchant1, Deirdre Burke2, Leah Shaw2, Hansel Tookes3, Dustin Patil4, Joshua A Barocas5, Alysse G Wurcel6.   

Abstract

People with opioid use disorder (OUD) have worse hospital outcomes and higher healthcare costs. There are rising reports of people with OUD also using other classes of drugs, however patterns of substance use have not been evaluated for differential effects on hospital outcomes. We performed a data-analysis of the Healthcare Utilization Project's National Readmissions Database, examining the effects of patterns of substance use, age, gender, and diagnosis on the outcomes of Against Medical Advice (AMA) discharges and 30-day readmissions. About one-third of the patients with OUD who were admitted to the hospital had at least one additional substance use disorder (SUD). Thirteen percent of persons with OUD were discharged AMA, and 12% were readmitted to the hospital within 30 days of discharge. Compared to people with OUD alone, people who used stimulants had increased odds of AMA discharge (aOR 1.83 (CI 1.73, 1.96)) and 30-day readmission (aOR 1.30 (95% CI 1.23, 1.37)). Multiple concomitant substance use disorders were associated with increased odds of AMA discharge and 30-day readmission. Conclusions: People with OUD have high rates of both AMA discharges and 30 day-readmissions, and there is a layered effect of increasing co-occurring SUDs leading to worse hospitalization outcomes. The heterogeneity of drug use patterns needs to be considered when developing strategies to improve health care outcomes for people with substance use disorder.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32199542      PMCID: PMC7089869          DOI: 10.1016/j.jsat.2020.01.010

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  50 in total

1.  Leaving against medical advice (AMA): risk of 30-day mortality and hospital readmission.

Authors:  Justin M Glasgow; Mary Vaughn-Sarrazin; Peter J Kaboli
Journal:  J Gen Intern Med       Date:  2010-04-28       Impact factor: 5.128

2.  Comorbidity measures for use with administrative data.

Authors:  A Elixhauser; C Steiner; D R Harris; R M Coffey
Journal:  Med Care       Date:  1998-01       Impact factor: 2.983

Review 3.  Pharmacotherapy for amphetamine dependence: A systematic review.

Authors:  Nicole K Lee; Linda Jenner; Angela Harney; Jacqui Cameron
Journal:  Drug Alcohol Depend       Date:  2018-08-22       Impact factor: 4.492

Review 4.  Polysubstance use: diagnostic challenges, patterns of use and health.

Authors:  Jason P Connor; Matthew J Gullo; Angela White; Adrian B Kelly
Journal:  Curr Opin Psychiatry       Date:  2014-07       Impact factor: 4.741

5.  Sociodemographic factors and social determinants associated with toxicology confirmed polysubstance opioid-related deaths.

Authors:  Joshua A Barocas; Jianing Wang; Brandon D L Marshall; Marc R LaRochelle; Amy Bettano; Dana Bernson; Curt G Beckwith; Benjamin P Linas; Alexander Y Walley
Journal:  Drug Alcohol Depend       Date:  2019-05-08       Impact factor: 4.492

Review 6.  Leaving the Hospital Against Medical Advice Among People Who Use Illicit Drugs: A Systematic Review.

Authors:  Lianping Ti; Lianlian Ti
Journal:  Am J Public Health       Date:  2015-10-15       Impact factor: 9.308

7.  Gender disparities in health care.

Authors:  Jennifer A Kent; Vinisha Patel; Natalie A Varela
Journal:  Mt Sinai J Med       Date:  2012 Sep-Oct

8.  US regional and demographic differences in prescription opioid and heroin-related overdose hospitalizations.

Authors:  George Jay Unick; Daniel Ciccarone
Journal:  Int J Drug Policy       Date:  2017-07-05

9.  Changes in Opioid-Involved Overdose Deaths by Opioid Type and Presence of Benzodiazepines, Cocaine, and Methamphetamine - 25 States, July-December 2017 to January-June 2018.

Authors:  R Matt Gladden; Julie O'Donnell; Christine L Mattson; Puja Seth
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2019-08-30       Impact factor: 17.586

10.  Increases in methamphetamine use among heroin treatment admissions in the United States, 2008-17.

Authors:  Christopher M Jones; Natasha Underwood; Wilson M Compton
Journal:  Addiction       Date:  2019-10-24       Impact factor: 7.256

View more
  5 in total

1.  Emergency Department Visits by Patients with Substance Use Disorder in the United States.

Authors:  Xingyu Zhang; Ningyuan Wang; Fengsu Hou; Yaseen Ali; Aaron Dora-Laskey; Chin Hwa Dahlem; Sean Esteban McCabe
Journal:  West J Emerg Med       Date:  2021-08-19

2.  Trends in Substance Use Disorder-related Admissions at a Safety-net Hospital, 2008 - 2020.

Authors:  Amber R Lindsay; Riley D Shearer; Gavin Bart; Tyler N A Winkelman
Journal:  J Addict Med       Date:  2022 May-Jun 01       Impact factor: 4.647

3.  Shifting North American drug markets and challenges for the system of care.

Authors:  R Michael Krausz; Jean N Westenberg; Nickie Mathew; George Budd; James S H Wong; Vivian W L Tsang; Marc Vogel; Conor King; Vijay Seethapathy; Kerry Jang; Fiona Choi
Journal:  Int J Ment Health Syst       Date:  2021-12-20

4.  Case report: acute care management of severe opioid withdrawal with IV fentanyl.

Authors:  Pouya Azar; Jean N Westenberg; Martha J Ignaszewski; James S H Wong; George Isac; Nickie Mathew; R Michael Krausz
Journal:  Addict Sci Clin Pract       Date:  2022-04-05

5.  Evaluating Differences in Opioid and Stimulant Use-associated Infectious Disease Hospitalizations in Florida, 2016-2017.

Authors:  David P Serota; Tyler S Bartholomew; Hansel E Tookes
Journal:  Clin Infect Dis       Date:  2021-10-05       Impact factor: 9.079

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.